Search

Your search keyword '"Gause-Nilsson, Ingrid A. M."' showing total 16 results
Start Over Author "Gause-Nilsson, Ingrid A. M." Database Unpaywall
16 results on '"Gause-Nilsson, Ingrid A. M."'

1. Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial

Author

Schechter, Meir, primary, Wiviott, Stephen D, additional, Raz, Itamar, additional, Goodrich, Erica L, additional, Rozenberg, Aliza, additional, Yanuv, Ilan, additional, Murphy, Sabina A, additional, Zelniker, Thomas A, additional, Fredriksson, Martin, additional, Johansson, Peter A, additional, Leiter, Lawrence A, additional, Bhatt, Deepak L, additional, McGuire, Darren K, additional, Wilding, John P H, additional, Gause-Nilsson, Ingrid A M, additional, Cahn, Avivit, additional, Langkilde, Anna Maria, additional, Sabatine, Marc S, additional, and Mosenzon, Ofri, additional

Published
2023
Full Text
View/download PDF

2. Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes

Author

Oyama, Kazuma, primary, Raz, Itamar, additional, Cahn, Avivit, additional, Goodrich, Erica L., additional, Bhatt, Deepak L., additional, Leiter, Lawrence A., additional, McGuire, Darren K., additional, Wilding, John P. H., additional, Gause-Nilsson, Ingrid A. M., additional, Mosenzon, Ofri, additional, Sabatine, Marc S., additional, and Wiviott, Stephen D., additional

Published
2022
Full Text
View/download PDF

3. Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58

Author

Cahn, Avivit, primary, Wiviott, Stephen D., primary, Mosenzon, Ofri, primary, Murphy, Sabina A., primary, Goodrich, Erica L., primary, Yanuv, Ilan, primary, Rozenberg, Aliza, primary, Bhatt, Deepak L., primary, Leiter, Lawrence A., primary, McGuire, Darren K., primary, Wilding, John P.H., primary, Gause-Nilsson, Ingrid A. M., primary, Langkilde, Anna Maria, primary, Sabatine, Marc S., primary, and Raz, Itamar, primary

Published
2022
Full Text
View/download PDF

4. Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58

Author

Cahn, Avivit, primary, Wiviott, Stephen D., primary, Mosenzon, Ofri, primary, Murphy, Sabina A., primary, Goodrich, Erica L., primary, Yanuv, Ilan, primary, Rozenberg, Aliza, primary, Bhatt, Deepak L., primary, Leiter, Lawrence A., primary, McGuire, Darren K., primary, Wilding, John P.H., primary, Gause-Nilsson, Ingrid A. M., primary, Langkilde, Anna Maria, primary, Sabatine, Marc S., primary, and Raz, Itamar, primary

Published
2022
Full Text
View/download PDF

5. Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE–TIMI 58 trial

Author

Oyama, Kazuma, primary, Raz, Itamar, additional, Cahn, Avivit, additional, Kuder, Julia, additional, Murphy, Sabina A, additional, Bhatt, Deepak L, additional, Leiter, Lawrence A, additional, McGuire, Darren K, additional, Wilding, John P H, additional, Park, Kyong Soo, additional, Goudev, Assen, additional, Diaz, Rafael, additional, Špinar, Jindřich, additional, Gause-Nilsson, Ingrid A M, additional, Mosenzon, Ofri, additional, Sabatine, Marc S, additional, and Wiviott, Stephen D, additional

Published
2021
Full Text
View/download PDF

6. The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

Author

Mosenzon, Ofri, primary, Wiviott, Stephen D, primary, Heerspink, Hiddo H J, primary, Dwyer, Jamie P, primary, Cahn, Avivit, primary, Goodrich, Erica L, primary, Rozenberg, Aliza, primary, Schechter, Meir, primary, Yanuv, Ilan, primary, Murphy, Sabina A, primary, Zelniker, Thomas A, primary, Gause-Nilsson, Ingrid A M, primary, Langkilde, Anna Maria, primary, Fredriksson, Martin, primary, Johansson, Peter A, primary, Bhatt, Deepak L, primary, Leiter, Lawrence A, primary, McGuire, Darren K, primary, Wilding, John P H, primary, Sabatine, Marc S, primary, and Raz, Itamar, primary

Published
2021
Full Text
View/download PDF

7. The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

Author

Mosenzon, Ofri, primary, Wiviott, Stephen D, primary, Heerspink, Hiddo H J, primary, Dwyer, Jamie P, primary, Cahn, Avivit, primary, Goodrich, Erica L, primary, Rozenberg, Aliza, primary, Schechter, Meir, primary, Yanuv, Ilan, primary, Murphy, Sabina A, primary, Zelniker, Thomas A, primary, Gause-Nilsson, Ingrid A M, primary, Langkilde, Anna Maria, primary, Fredriksson, Martin, primary, Johansson, Peter A, primary, Bhatt, Deepak L, primary, Leiter, Lawrence A, primary, McGuire, Darren K, primary, Wilding, John P H, primary, Sabatine, Marc S, primary, and Raz, Itamar, primary

Published
2021
Full Text
View/download PDF

8. The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

Author

Mosenzon, Ofri, primary, Wiviott, Stephen D, primary, Heerspink, Hiddo H J, primary, Dwyer, Jamie P, primary, Cahn, Avivit, primary, Goodrich, Erica L, primary, Rozenberg, Aliza, primary, Schechter, Meir, primary, Yanuv, Ilan, primary, Murphy, Sabina A, primary, Zelniker, Thomas A, primary, Gause-Nilsson, Ingrid A M, primary, Langkilde, Anna Maria, primary, Fredriksson, Martin, primary, Johansson, Peter A, primary, Bhatt, Deepak L, primary, Leiter, Lawrence A, primary, McGuire, Darren K, primary, Wilding, John P H, primary, Sabatine, Marc S, primary, and Raz, Itamar, primary

Published
2021
Full Text
View/download PDF

9. The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

Author

Mosenzon, Ofri, primary, Wiviott, Stephen D, primary, Heerspink, Hiddo H J, primary, Dwyer, Jamie P, primary, Cahn, Avivit, primary, Goodrich, Erica L, primary, Rozenberg, Aliza, primary, Schechter, Meir, primary, Yanuv, Ilan, primary, Murphy, Sabina A, primary, Zelniker, Thomas A, primary, Gause-Nilsson, Ingrid A M, primary, Langkilde, Anna Maria, primary, Fredriksson, Martin, primary, Johansson, Peter A, primary, Bhatt, Deepak L, primary, Leiter, Lawrence A, primary, McGuire, Darren K, primary, Wilding, John P H, primary, Sabatine, Marc S, primary, and Raz, Itamar, primary

Published
2021
Full Text
View/download PDF

10. Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58

Author

Cahn, Avivit, primary, Raz, Itamar, primary, Leiter, Lawrence A., primary, Mosenzon, Ofri, primary, Murphy, Sabina A., primary, Goodrich, Erica L., primary, Yanuv, Ilan, primary, Rozenberg, Aliza, primary, Bhatt, Deepak L., primary, McGuire, Darren K., primary, Wilding, John P.H., primary, Gause-Nilsson, Ingrid A. M., primary, Langkilde, Anna Maria, primary, Sabatine, Marc S., primary, and Wiviott, Stephen D., primary

Published
2021
Full Text
View/download PDF

11. Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58

Author

Cahn, Avivit, primary, Raz, Itamar, primary, Leiter, Lawrence A., primary, Mosenzon, Ofri, primary, Murphy, Sabina A., primary, Goodrich, Erica L., primary, Yanuv, Ilan, primary, Rozenberg, Aliza, primary, Bhatt, Deepak L., primary, McGuire, Darren K., primary, Wilding, John P.H., primary, Gause-Nilsson, Ingrid A. M., primary, Langkilde, Anna Maria, primary, Sabatine, Marc S., primary, and Wiviott, Stephen D., primary

Published
2021
Full Text
View/download PDF

12. Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58

Author

Cahn, Avivit, primary, Wiviott, Stephen D., additional, Mosenzon, Ofri, additional, Murphy, Sabina A., additional, Goodrich, Erica L., additional, Yanuv, Ilan, additional, Rozenberg, Aliza, additional, Wilding, John P. H., additional, Leiter, Lawrence A., additional, Bhatt, Deepak L., additional, McGuire, Darren K., additional, Litwak, Leon, additional, Kooy, Adriaan, additional, Gause‐Nilsson, Ingrid A. M., additional, Fredriksson, Martin, additional, Langkilde, Anna Maria, additional, Sabatine, Marc S., additional, and Raz, Itamar, additional

Published
2020
Full Text
View/download PDF

13. Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE‐TIMI 58 study

Author

Cahn, Avivit, primary, Raz, Itamar, additional, Bonaca, Marc, additional, Mosenzon, Ofri, additional, Murphy, Sabina A., additional, Yanuv, Ilan, additional, Rozenberg, Aliza, additional, Wilding, John P. H., additional, Bhatt, Deepak L., additional, McGuire, Darren K., additional, Gause‐Nilsson, Ingrid A. M., additional, Fredriksson, Martin, additional, Johansson, Peter A., additional, Jermendy, Gyorgy, additional, Hadjadj, Samy, additional, Langkilde, Anna Maria, additional, Sabatine, Marc S., additional, Wiviott, Stephen D., additional, and Leiter, Lawrence A., additional

Published
2020
Full Text
View/download PDF

14. Cardiovascular and renal benefits of dapagliflozin in patients with short and long‐standing type 2 diabetes: Analysis from the DECLARE‐TIMI 58 trial

Author

Bajaj, Harpreet S., primary, Raz, Itamar, additional, Mosenzon, Ofri, additional, Murphy, Sabina A., additional, Rozenberg, Aliza, additional, Yanuv, Ilan, additional, Bhatt, Deepak L., additional, Leiter, Lawrence A., additional, McGuire, Darren K., additional, Wilding, John P. H., additional, Gause‐Nilsson, Ingrid A. M., additional, Sabatine, Marc S., additional, Wiviott, Stephen D., additional, and Cahn, Avivit, additional

Published
2020
Full Text
View/download PDF

15. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial

Author

Mosenzon, Ofri, primary, Wiviott, Stephen D, additional, Cahn, Avivit, additional, Rozenberg, Aliza, additional, Yanuv, Ilan, additional, Goodrich, Erica L, additional, Murphy, Sabina A, additional, Heerspink, Hiddo J L, additional, Zelniker, Thomas A, additional, Dwyer, Jamie P, additional, Bhatt, Deepak L, additional, Leiter, Lawrence A, additional, McGuire, Darren K, additional, Wilding, John P H, additional, Kato, Eri T, additional, Gause-Nilsson, Ingrid A M, additional, Fredriksson, Martin, additional, Johansson, Peter A, additional, Langkilde, Anna Maria, additional, Sabatine, Marc S, additional, and Raz, Itamar, additional

Published
2019
Full Text
View/download PDF

16. DECLARE‐TIMI 58: Participants’ baseline characteristics

Author

Raz, Itamar, primary, Mosenzon, Ofri, additional, Bonaca, Marc P., additional, Cahn, Avivit, additional, Kato, Eri T., additional, Silverman, Michael G., additional, Bhatt, Deepak L., additional, Leiter, Lawrence A., additional, McGuire, Darren K., additional, Wilding, John P. H., additional, Gause‐Nilsson, Ingrid A. M., additional, Langkilde, Anna M., additional, Johansson, Peter A., additional, Sabatine, Marc S., additional, and Wiviott, Stephen D., additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results